Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17-(2-hydroxy-1-oxopropyl)-17-methylestra-4,9-dien-3-one
2. 21-hydroxypromegestone
3. Ru 27987
4. Ru 27988
5. Ru-27987
6. Ru-27988
7. Trimegestone, (17beta(r))-isomer
1. 74513-62-5
2. Ru 27987
3. Ru-27987
4. 4658k0h08w
5. Trimegestone [inn]
6. Totelle Sekvens, Ondeva
7. Ondeva
8. Trimegestone [usan:inn:ban]
9. Unii-4658k0h08w
10. (8s,13s,14s,17s)-17-[(2s)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
11. Trimegestone (usan/inn)
12. Trimegestone [usan]
13. Trimegestone [mart.]
14. Schembl518768
15. Trimegestone [who-dd]
16. Chembl2104765
17. Chebi:136027
18. Dtxsid201317995
19. Zinc4217604
20. Akos015967450
21. At35938
22. Db13129
23. Ac-24967
24. D06235
25. 513t625
26. A838156
27. Q7842164
28. 17beta-(s)-lactoyl-17-methylestra-4,9-dien-3-one
29. 17.beta.-(s)-lactoyl-17-methylestra-4,9-dien-3-one
30. Estra-4,9-dien-3-one, 17-(2-hydroxy-1-oxopropyl)-17-methyl-, (17.beta.(s))-
31. Estra-4,9-dien-3-one, 17-(2-hydroxy-1-oxopropyl)-17-methyl-, (17beta(s))-
| Molecular Weight | 342.5 g/mol |
|---|---|
| Molecular Formula | C22H30O3 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 342.21949481 g/mol |
| Monoisotopic Mass | 342.21949481 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 700 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Trimegestone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimegestone, including repackagers and relabelers. The FDA regulates Trimegestone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimegestone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimegestone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimegestone supplier is an individual or a company that provides Trimegestone active pharmaceutical ingredient (API) or Trimegestone finished formulations upon request. The Trimegestone suppliers may include Trimegestone API manufacturers, exporters, distributors and traders.
click here to find a list of Trimegestone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimegestone DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimegestone active pharmaceutical ingredient (API) in detail. Different forms of Trimegestone DMFs exist exist since differing nations have different regulations, such as Trimegestone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimegestone DMF submitted to regulatory agencies in the US is known as a USDMF. Trimegestone USDMF includes data on Trimegestone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimegestone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimegestone suppliers with USDMF on PharmaCompass.
Trimegestone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimegestone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimegestone GMP manufacturer or Trimegestone GMP API supplier for your needs.
A Trimegestone CoA (Certificate of Analysis) is a formal document that attests to Trimegestone's compliance with Trimegestone specifications and serves as a tool for batch-level quality control.
Trimegestone CoA mostly includes findings from lab analyses of a specific batch. For each Trimegestone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimegestone may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimegestone EP), Trimegestone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimegestone USP).
LOOKING FOR A SUPPLIER?
